VivoSim Labs/$VIVS
13:30
03:10
16:45
06:25
20:00
1D1W1MYTD1Y5YMAX
About VivoSim Labs
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.
Ticker
$VIVS
Sector
Primary listing
Industry
Biotechnology
Headquarters
Employees
9
ISIN
US68620A3023
Website
VivoSim Labs Metrics
BasicAdvanced
$3.7M
-
-$1.70
1.04
-
Price and volume
Market cap
$3.7M
Beta
1.04
52-week high
$4.15
52-week low
$1.41
Average daily volume
104K
Financial strength
Current ratio
3.246
Quick ratio
3.035
Long term debt to equity
4.013
Total debt to equity
8.978
Interest coverage (TTM)
-1,261.60%
Profitability
EBITDA (TTM)
-12.35
Gross margin (TTM)
-3,393.06%
Net profit margin (TTM)
-1,727.78%
Operating margin (TTM)
-8,761.11%
Effective tax rate (TTM)
-0.08%
Revenue per employee (TTM)
$20,000
Management effectiveness
Return on assets (TTM)
-75.10%
Return on equity (TTM)
-35.31%
Valuation
Price to revenue (TTM)
14.332
Price to book
0.26
Price to tangible book (TTM)
0.26
Price to free cash flow (TTM)
-0.218
Free cash flow yield (TTM)
-459.05%
Free cash flow per share (TTM)
-647.30%
Growth
Revenue change (TTM)
32.11%
Earnings per share change (TTM)
-91.17%
3-year revenue growth (CAGR)
-54.21%
10-year revenue growth (CAGR)
-12.87%
3-year earnings per share growth (CAGR)
-52.42%
10-year earnings per share growth (CAGR)
-32.81%
VivoSim Labs News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for VivoSim Labs stock?
VivoSim Labs (VIVS) has a market cap of $3.7M as of June 20, 2025.
What is the P/E ratio for VivoSim Labs stock?
The price to earnings (P/E) ratio for VivoSim Labs (VIVS) stock is 0 as of June 20, 2025.
Does VivoSim Labs stock pay dividends?
No, VivoSim Labs (VIVS) stock does not pay dividends to its shareholders as of June 20, 2025.
When is the next VivoSim Labs dividend payment date?
VivoSim Labs (VIVS) stock does not pay dividends to its shareholders.
What is the beta indicator for VivoSim Labs?
VivoSim Labs (VIVS) has a beta rating of 1.04. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
